Gain Therapeutics Inc.

NASDAQ: GANX · Real-Time Price · USD
1.73
0.19 (12.34%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:49 PM EDT

Gain Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-2.42 -1.91 -2.11 -3.97
PEG Ratio
0.05 -0.12 -0.26 -0.01
PS Ratio
n/a 771.06 265.47 334.55
PB Ratio
6.73 3.38 1.97 1.59
P/FCF Ratio
-2.62 -2.25 -2.51 -4.43
P/OCF Ratio
-2.62 -2.26 -2.53 -4.46
OCF/S Ratio
n/a -341.9 -104.86 -74.95
Debt / Equity Ratio
0.09 0.08 0.07 0.05
Quick Ratio
2.97 3.59 5.11 14.78
Current Ratio
2.97 3.59 5.11 14.78
Asset Turnover
n/a 0.00 0.01 0.00
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-2.78 -1.77 -0.93 -0.4
Return on Assets
-1.68 -1.2 -0.73 -0.36
Return on Invested Capital
-2.46 -1.59 -0.88 -0.38
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
n/a -0.46 0.54 -42.42
Net Profit Margin
n/a -403.54 -125.55 -84.19
Pretax Profit Margin
n/a -402.11 -124.89 -84.16
Operating Profit Margin
n/a -403.28 -126.88 -83.8
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
n/a -401.77 -126.88 -83.77